Slide 1

German Cancer Consortium (DKTK)

DOSE CONSTRAINTS:

HEART

Adebahr et al ,BJR, accepted 04/2015

• 16 pts with paracardiac

and cardiac lesions

• 30-36 Gy, 3# (70%)

• D100%: 51.4 Gy

• EQD2 (αβ3):108-204 Gy

• BED3: 240 Gy

• no cardiological symptoms

or electrocardiographic abnormalities, even months after SBRT

• 1 clinically irrelevant, pericardial effusion (PCE) at 3 months, disappeared at follow-up

Bonomo et al. Radiol med 2013